S Sone. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetylmuramyl-Alanyl-Isoglutamine/administration & dosageAcetylmuramyl-Alanyl-Isoglutamine/analogs & derivativesAcetylmuramyl-Alanyl-Isoglutamine/pharmacologyAcetylmuramyl-Alanyl-Isoglutamine/therapeutic useAnimalsAntigen-Presenting Cells/immunologyCarcinogens/metabolismGuinea PigsHumansInterferons/administration & dosageInterferons/pharmacologyInterferons/therapeutic useKiller Cells, Natural/immunologyLipopolysaccharides/pharmacologyLiposomesLung Diseases, Fungal/immunologyLung Neoplasms/etiologyLung Neoplasms/metabolismLung Neoplasms/pathologyLung Neoplasms/physiopathologyLung Neoplasms/therapyLymphokines/administration & dosageLymphokines/pharmacologyLymphokines/therapeutic useMacrophage Activation/drug effectsMacrophage-Activating FactorsMacrophages/drug effectsMacrophages/immunologyMacrophages/physiologyMelanoma/metabolismMelanoma/pathologyMicePhagocytosisPhosphatidylethanolamines/administration & dosagePhosphatidylethanolamines/pharmacologyPhosphatidylethanolamines/therapeutic usePneumonia/immunologyPulmonary Alveoli/pathologyRatsT-Lymphocytes, Cytotoxic/immunology
Substances: See more » CarcinogensLipopolysaccharidesLiposomesLymphokinesMacrophage-Activating FactorsPhosphatidylethanolaminesmifamurtideAcetylmuramyl-Alanyl-IsoglutamineInterferons
Year: 1986 PMID: 2423125 DOI: 10.1016/0304-419x(86)90004-1
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002